Clinical Trials Logo

Filter by:
NCT ID: NCT02929888 Recruiting - Clinical trials for Acute Myocardial Infarction

Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients

ECCLIPSE-STEMI
Start date: October 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Prasugrel and ticagrelor, new P2Y12-ADP receptor antagonists, are associated with greater pharmacodynamic inhibition and reduction of cardiovascular events in patients with an acute coronary syndrome. However, evidence is lacked about the effects of achieving faster and stronger cyclooxygenase inhibition with intravenous lysine acetylsalicylate (LA) compared to oral aspirin on prasugrel inhibited platelets. Recently, we demonstrated in healthy volunteers that the administration of intravenous LA resulted in a significantly reduction of platelet reactivity compared to oral aspirin on prasugrel inhibited platelets. Loading dose of LA achieves platelet inhibition faster, greater and with less variability than aspirin. However, there are no data of this issue in patients with an ST-segment elevation myocardial infarction (STEMI). The ECCLIPSE-STEMI trial will study the effect of LA versus aspirin in platelet reactivity in patients with STEMI

NCT ID: NCT02928484 Recruiting - Dyspepsia Clinical Trials

Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function

Start date: June 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this pilot study is to evaluate whether a probiotic supplement improves gastrointestinal (GI) function.

NCT ID: NCT02928276 Recruiting - Clinical trials for Rheumatoid Arthritis

Predictive Analytics for Theranosis in RA

PAnTheRA
Start date: November 2016
Phase: N/A
Study type: Interventional

RA is the most common inflammatory, persistent and progressive disease of the joints with serious co-morbidities and huge health and socio-economic impact worldwide.

NCT ID: NCT02925845 Recruiting - Clinical trials for Arteriovenous Fistula

Neuromuscular Electrostimulation in Radiocephalic Fistula

NMS
Start date: January 2015
Phase: N/A
Study type: Interventional

- Objective: To analyze the effect of neuromuscular electrostimulation in the maturation of radiocephalic arteriovenous fistula (RC-AVF) patients with chronic kidney disease (CKD) stage 5-5D - Design: Clinical Trial with medical devices, 18-month, single-center, within the hospital setting. - Disease or disorder study: vascular Access maturation. - Population: Patients with CKD stage 5-5D at the research center. - Project duration: 78 weeks - Methodology: - Patients with CKD stages 5-5D that has undergone a native AV in service stations to give their informed consent and meeting the inclusion criteria will be included. - At baseline two study groups were established: - Group 1: neuromuscular electrostimulation - Group 2: isometric exercises

NCT ID: NCT02924870 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Long-term Effect of an Health Education Program on Daily Physical Activity in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

EA-EPOC
Start date: October 2016
Phase: Phase 4
Study type: Interventional

Main objective: To compare the level of physical activity (PAL) at 12 months in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) between those who completed a health education program and those who did not. Study patients. Subjects older than 35 years; diagnosis of moderate to very severe COPD (FEV1 <80% predicted), established at least 3 months; current or former smoker with an accumulated consumption >10 packs x year; and hospital admission for COPD exacerbation. Design. Randomized, parallel and open-label clinical trial, controlled with conventional treatment. Intervention: During hospitalization, selected patients will receive conventional treatment. At discharge, they will be randomized (1:1) to control group [treatment and follow-up according to conventional clinical practice] or intervention group [in addition to conventional treatment and follow-up, the patients will be referred to a nursing consultation for perform two health education sessions, at 15 and 30 days after hospital discharge]. Measurements. At 15 days and 12 months after discharge, the following determinations will be made: anthropometric characteristics; clinical evaluation (smoking history, date of COPD diagnosis, comorbidities, current medication; health care utilization; moderate or severe COPD exacerbations); questionnaires (mMRC, Charlson, COPD-specific co-morbidity test (COTE), COPD Assessment Test (CAT) and LCADL), spirometry and six-minutes walking test; and evaluation of daily physical activity using an accelerometer.

NCT ID: NCT02923076 Recruiting - HIV Clinical Trials

HIV Eradication Through Cord-blood Transplantation

HIVECT
Start date: June 2016
Phase: N/A
Study type: Interventional

Allogeneic hematopoietic cell transplantation from a CCR5 Δ32/Δ32 unrelated donor, performed for the first time in the "Berlin patient", provides the only evidence to date of long-term control of HIV infection. Stringent criteria to select human leukocyte antigen (HLA)-matched conventional donors and low prevalence of the CCR5 Δ32/Δ32 homozygous genotype (<1%) made the pursuit of "patient number 2" unsuccessful for many years. Cord blood (CB) transplantation allows more permissive HLA-matching criteria, making the search for HLA-compatible Δ32/Δ32 CB units potentially feasible for transplantation of HIV-infected individuals. The investigator team involved in this trial has recently reported the first such case of CCR5 delta32/delta32 CB transplantation in a patient with HIV infection, showing a reduction of the patient's latent viral reservoir and, upon achievement of full CB chimerism, resistance of his CD4 T-lymphocytes to infection by HIV. This proof of concept led the Spanish National Transplant Organization (ONT) to generate an inventory of over 150 CCR5 Δ32/Δ32 CB units readily available for transplant. From this initial evidence and repository of CB units, financial support from the Fundación Mutua Madrileña (FMM) has allowed the investigators to launch this first pilot clinical trial in this indication. The study was launched in January 2016 at Hospital Universitario Puerta de Hierro Majadahonda. All HIV virology and reservoir analyses are carried out by the AIDS Immunopathology Unit at the Spanish Instituto de Salud Carlos III. Three additional transplant centres in Spain will also shortly open the trial.

NCT ID: NCT02921217 Recruiting - Obesity Clinical Trials

Effect of a Probiotic on Visceral Fat Accumulation

BIFFAT
Start date: July 2016
Phase: Phase 3
Study type: Interventional

The study's main objective is to investigate if an extract containing the probiotic Bifidobacterium animalis subsp. lactis BPL1 (CECT 8145) has a positive effect on the accumulation of abdominal visceral fat in people with abdominal obesity.

NCT ID: NCT02919059 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.

Start date: December 13, 2016
Phase: Phase 4
Study type: Interventional

This superiority of central pressure versus peripheral measures to predict cardiovascular events has also been reported in general population or in elder people

NCT ID: NCT02917291 Recruiting - Clinical trials for Acute Traumatic Spinal Cord Injury

Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury

SPINE
Start date: December 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The main objective of the study is the evaluation of the safety and tolerability of FAB117-HC (a medicinal product containing human allogeneic adipose derived adult mesenchymal stem cells expanded and pulsed with H2O2, HC016 cells) administered at a single-time point to patients with acute thoracic traumatic spinal cord injury (SCI). The study will also include initial exploration of potential clinical efficacy. Dose levels of 20 million and 40 million cells will be administered.

NCT ID: NCT02915120 Recruiting - Clinical trials for Osteoarthritis, Knee

Ultrasound-Guided Pulsed Radiofrequency In The Treatment Of Patients With Osteoarthritis Knee (USPRFGENOAK)

USPRFGENOAK
Start date: March 27, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if patients with chronic painful knee osteoarthritis experience meaningful and long-term improvement in pain, function, and analgesic use after ultrasound-guided pulsed radiofrequency of the genicular nerves following a double diagnostic genicular nerve blocks.